Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
about
Photosensitivity, corneal scarring and developmental delay: Xeroderma Pigmentosum in a tropical countryUpdated Physician's Guide to the Off-label Uses of Oral IsotretinoinMechanisms of Photoaging and Cutaneous Photocarcinogenesis, and Photoprotective Strategies with PhytochemicalsRetinoids for prevention and treatment of actinic keratosisRetinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cellsRetinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human EpidermisEpidemiology of basal cell carcinoma: scholarly review.Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients.Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations.Difluoromethylornithine: the proof is in the polyamines.Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrenceOphthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literatureCurrent sunscreen controversies: a critical review.Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancerTargeting ornithine decarboxylase for the prevention of nonmelanoma skin cancer in humans.Turning back the clock: retinoic acid modifies intrinsic aging changes.Retinoid chemoprevention in patients at high risk for skin cancer.Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.Cyclin proteolysis as a retinoid cancer prevention mechanism.Specific cell-signal targets for cancer chemotherapy.Genetic alterations in carcinogenesis and chemoprevention.Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.Retinoids and photodamage.Isotretinoin and FoxO1: A scientific hypothesis.Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.Fenretinide: a prototype cancer prevention drug.Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.Retinoid protection against x-ray-induced chromatid damage in human peripheral blood lymphocytes.Basal cell carcinomas: attack of the hedgehog.Shining a light on xeroderma pigmentosum.Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production.Cellular localization of retinoic acid receptor-gamma expression in normal and neoplastic skin.Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitroThe receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal.A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
P2860
Q21198823-EE7DF97D-D472-491D-BA96-8A8BC715FB14Q24568006-DC379090-F110-402C-821A-4FF16A6FD6FFQ26771213-430373AE-6021-423B-906A-7C04CE5D7C7AQ27004066-BBDBEAE2-5644-4EB1-B0D0-766EE2146DF5Q28316144-7D7FD208-F1C5-4951-8E91-177984489DACQ28551362-4AE91B2B-6EE2-4C58-89AD-DC9681D4CA0CQ30235834-7EF3CCF6-7811-4E9C-A8F9-8652ED6329FDQ31136160-6F1D7B89-6473-465D-9F52-42A8D3CBA04CQ33590419-DE27936F-7A7F-4943-834B-F12F36A41577Q33596422-B5DA8B63-68CE-46AC-93C0-D303F36821A6Q33859016-D9502C0D-EC40-40B8-88EE-781943BFE198Q33900912-D343AE44-71DC-42CD-B78D-460D273DD20BQ33922877-16D0233B-E109-4668-9B61-F6A9677A7A32Q33935815-9D6D0CA9-65C8-44B6-A847-A182DA6B11B4Q34026049-AC1A64E1-216C-4B4C-A938-DDD9BC53610FQ34066208-9EDCBBED-EFD2-4135-8AA1-4EB81187DB0BQ34080312-D9FAD3AC-8C48-4FAF-B1CA-C49D92E585C7Q34155451-5893D87D-4E8F-45CE-B96D-07D724E4CFF2Q34243532-D7FA8AA0-A29D-4F85-800E-DB252430557CQ34406418-16381505-02B5-438D-9A17-EF0B608CD20DQ34497372-CC0B29F4-F1D3-4B01-A11F-A05D28CCE1A4Q34556052-1CE3BCA8-FC66-43EE-AD33-5968616D5E45Q34856788-75C6C412-24C4-40B8-8FC3-232AA33D1BDDQ35068938-FEC13C70-6CE4-4302-AEC7-8BF2AE6E970BQ35164298-F1A13300-A53A-4758-90C1-D1BF8FED7689Q35358528-51AF69D0-58E6-42BE-A9F8-CED7AA08D660Q35558873-A40F4149-B55E-4397-ABA7-04DDA4CC7E45Q35567825-D3FB0866-C02C-44F0-ACEF-6972BFE08706Q35570960-A64A1FB9-9051-4E68-947B-0F31609F9324Q35605167-5459C8BA-D823-461A-B170-4262A529FFF4Q35609265-967F1508-84D8-4B4D-9DA3-FD67B36A970BQ35687900-1FDEC223-87EE-4C57-8ABB-413A21B76863Q35757364-505526FA-71C9-4BA8-AA8B-51E2625C418DQ35818219-ABE510C4-0D47-4713-B92C-C0AAB97C55C1Q35831808-AAFAE21E-41CB-4206-9B12-FD7C4C1D45BDQ36002283-0869A1DB-86CD-440A-AC90-1CC981584904Q36369396-C501597A-1910-4B0B-B9B7-99092E95BD58Q36417111-159674A0-D82F-411F-ABF3-6AB8AF4CF921Q36561262-44CF2D85-C21E-4F15-902A-8CD9F352C6D9Q36622068-A5DE998D-8389-4B40-906C-90BC1E44DAEF
P2860
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@ast
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@en
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@nl
type
label
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@ast
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@en
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@nl
prefLabel
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@ast
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@en
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@nl
P2093
P3181
P1476
Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
@en
P2093
A N Moshell
J J DiGiovanna
K H Kraemer
R E Tarone
P304
P3181
P356
10.1056/NEJM198806233182501
P407
P577
1988-06-23T00:00:00Z